remedē System Therapy Study

Moderate to severe central sleep apnea (AHI ≥ 15 events per hour) based on a sleep study scored by a local sleep laboratory. It is strongly recommended that a patient have a diagnostic PSG within 12 months of the expected implant date documenting moderate to severe CSA.

Age 18 years or older

Signed Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved informed consent

In the opinion of the investigator, subject is willing and able to comply with the protocol.

Not currently enrolled in another investigational study or registry that would directly interfere with the current study, except if the subject is participating in a mandatory government registry, or a purely observational registry with no associated treatments. Each instance should be brought to the attention of the sponsor to determine eligibility.

In the opinion of the Investigator, life expectancy exceeds one year.

The subject is not pregnant or planning to become pregnant.